Related Experiment Video
Updated: Jun 11, 2025

Assessment and Evaluation of the High Risk Neonate: The NICU Network Neurobehavioral Scale
Published on: August 25, 2014
Prenatal Substance Exposure and Infant Discharge Placement: Results From the ACT NOW Study
Tre D Gissandaner1, Jordan A Gette2, Kristin J Perry3,4
1Department of Psychiatry, Columbia University Irving Medical Center, New York, NY, USA.
Insights
Infants exposed to substances during pregnancy, especially poly-substance use, face a higher risk of out-of-home placement. Withdrawal severity also impacts discharge decisions for these vulnerable infants.
Area of Science:
- Pediatrics
- Neonatal Care
- Public Health
Background:
- Identifying infants at risk for out-of-home placement is crucial.
- Prenatal substance exposure and demographic factors influence placement decisions.
Purpose of the Study:
- To examine factors associated with out-of-home placement for infants with prenatal substance exposure.
- To identify specific substance exposure patterns and withdrawal severity linked to placement outcomes.
Main Methods:
- Utilized a validated medical record data extraction tool on data from the ACT NOW study (N=30 sites).
- Analyzed data from 1808 birthing parent-infant dyads with documented Neonatal Opioid Withdrawal Syndrome (NOWS) scoring or prenatal opioid exposure.
- Employed latent class analysis to identify substance use patterns and their association with discharge destinations.
Main Results:
- Infants with prenatal exposure to alcohol, cocaine, meth/amphetamine, and opioids had lower probabilities of discharge to parents.
- Latent class analysis revealed distinct substance use classes associated with varying discharge probabilities.
- Less than half of infants in the Poly-use and Meth/amphetamine classes were discharged to parents (47%-49%).
- Withdrawal symptom severity influenced placement decisions in Poly-use and Prescription Opioid classes.
Conclusions:
- Prenatal substance exposure, particularly poly-substance use and meth/amphetamine exposure, significantly reduces the likelihood of infant discharge to parental care.
- Infant withdrawal severity is a critical factor in placement decisions for specific substance exposure classes.
- Findings support the need for enhanced support, identification, and safe care plans for substance-exposed infants and their families.
Abstract:
It is critical that researchers gather evidence of factors that identify infants at risk of out-of-home placement based on types of substance exposures and demographic characteristics. This study applied a validated medical record data extraction tool on data derived from a multi-site (N = 30) pediatric clinical trials network (ISPCTN) study of Neonatal Opioid Withdrawal (ACT NOW study). Participants included 1808 birthing parent-infant dyads with documented NOWS scoring or prenatal opioid exposure. Non-Hispanic White pregnant persons comprised the largest proportion of the sample (69.8%), followed by Non-Hispanic Black (11.6%), Non-Hispanic Multiracial and Other race (8.5%), and Hispanic (6.2%). Most notably, infant prenatal substance exposure across alcohol, cocaine, meth/amphetamine, and opioids, had the lowest possibility of discharging to parent(s). Additionally, latent class analysis identified distinct classes of substance use during pregnancy that were associated with different probabilities of discharging to parent(s). Specifically, less than half of infants (47%-49%) in the Poly-use and Meth/amphetamine classes were discharged to their parent(s). Severity of infant withdrawal symptoms influenced placement decisions within the Poly-use and Prescription Opioid classes. Findings can inform standard practices for increasing support for pregnant persons and substance-exposed infants including identification, subsequent referrals, communication with Child Protective Services, and plans of safe care.
More Related Videos
Related Concept Videos
Discharge Summary Forms
Here's a detailed look at the key components and guidelines for preparing a discharge summary:
Drug Excretion: Pulmonary and Glandular Routes
Drugs can also be excreted in breast milk, which is crucial for breastfeeding infants. The...
Types of Toxins
Air pollutants, primarily gases, pose significant threats to respiratory health, leading to conditions like hypoxia, lung cancer, and in extreme cases, death.
Environmental pollutants like...
Upper Respiratory Drugs: Antitussives, Expectorants, and Mucolytics
Antitussives include codeine, dextromethorphan (Robitussin), and benzonatate (Tessalon). Codeine and dextromethorphan exert their effects centrally by suppressing the cough reflex center in the medulla. Benzonatate operates peripherally within the respiratory tract by...
Toxic Reactions: Overview
Toxicity falls into two primary categories: local and systemic.
Local toxicity appears at the exposure site, such as protein denaturation caused by caustic substances.
In contrast, systemic toxicity requires the toxic agent's absorption and distribution,...
Drug Excretion: Miscellaneous Routes

